Morphogenesis, Inc. Is Testing Cancer Vaccine
Scientists at UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, call the “therapeutic vaccine” a simple and safe technology that could help people who already have cancer fight it off. Six patients with stage three and stage four melanoma started the trial in November 2018. Morphogenesis, Inc., is working with specialists at Moffitt […]
Virtual Humans Boost Mental Health Recovery
Benjamin Lok, a professor in the computer and information science and engineering department at the University of Florida, has been studying applications of virtual humans for two decades. His research has led to the creation of dozens of virtual characters that appear in 1,500 different programs around the world and wrack up over a million […]
Startup CEO Discusses Business Growth After Receiving Funding
UF startup Peerfit founder and CEO Ed Buckley gained a lot of traction with his business after receiving investment funding and coaching from organizations like Florida Funders. Peerfit promotes corporate wellness by giving the workforce access to exercise classes and programs through an interactive tech platform. The company grew from just four employees to more […]
Morphogenesis, Inc. Is Developing a Cell and Gene Therapy Focusing on a Cancer Vaccine Immunotherapy That Uses the Body’s Own Immune System to Kill Solid Tumors
Dr. Patricia Lawman, CEO and co-founder of UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, talks about the company, their projects – current and future – and the challenges she and her team have to face while developing cell and gene therapy technologies. “We are currently focusing on our cancer vaccine. This […]
Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) Exhibited Potent Anti-Fibrotic Activity in NASH and CKD Studies
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, is pleased to report that its lead drugs for non-alcoholic steatohepatitis (NASH) and chronic kidney disease (CKD) Bemethyl (NP-135) and Bromantane (NP-160), exhibited highly statistically significant anti-fibrotic activity and outperformed known anti-fibrotic agents Telmisartan and Cenicriviroc. “We are planning off-label phase II clinical trials for […]
US Biotech Startup Eyes 2020 Avian Necrotic Enteritis Vaccine Launch
Founded in 2015, UF startup Curtiss Healthcare commercialized UF researcher Dr. Roy Curtiss III’s research into orally distributed Salmonella vector vaccines. The startup, a resident client at UF Innovate | Sid Martin Biotech, is developing a platform of vaccines for chickens with a view toward becoming the head of an antibiotic-free animal health industry in […]
Pheromones Give Nematodes a Boost in Controlling Pests
UF Innovate alumni startup Pheronym, an ag-biotech pest control company that develops and produces nematode pheromones that can be used to direct beneficial nematode behavior, has established a cooperative research agreement with the Agricultural Research Service (ARS). The ARS team, Pheronym CEO Fatma Kaplan, and Ed Lewis, head of the Department of Entomology, Plant Pathology, […]
AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Study
UF startup and UF Innovate│Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has completed enrollment of the third group in the dose-escalation portion of its Phase 1/2 clinical trial evaluating the safety […]
Sun BioPharma, Inc. Provides an Update on Ongoing Front-Line Pancreatic Cancer Clinical Trial
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, provides an update on the Company’s current clinical trial. Following successful conclusion of the first SBP-101 dose-escalation study in heavily pretreated pancreatic cancer patients that showed SBP-101 could be administered safely as monotherapy, a second Phase 1 […]
Morphogenesis, Inc. Moves Forward With Development of Cancer Vaccine
UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, has been working on the research for nearly 20 years and has already completed phase one of its clinical trial on the treatment which the company says will be directly inserted into cancerous tumors through several methods. “It actually triggers the early response and […]